UBS trims Haleon growth forecast to 3.1 percent for Haleon stock

Published on 10/15/2026 at 13:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

UBS cut its 2026 growth forecast from 3.4 to 3.1 percent on October 12, 2026. Haleon stock costs EUR 4.42 on October 15, 2026.

Growth and reporting dates

UBS cut its 2026 organic growth forecast from 3.4 percent to 3.1 percent on October 12, 2026.
Haleon's first-half 2026 revenue reached GBP 5.602 billion, with organic growth of 2.6 percent.
Haleon stock was trading at EUR 4.42 at 1:11 p.m. CEST at Lang & Schwarz on October 15, 2026.
Haleon's next scheduled trading statement is October 29, 2026.

Makroaufnahme einer Zahnpastaschlaufe neben glänzenden gelben Vitaminkapseln — Haleon plc (ISIN GB00BMX86B70) stellt Zahnpflegeprodukte und Nahrungsergänzungsmittel für Verbraucher weltweit her, Illustration mit AI erstellt.

Haleon (ISIN GB00BMX86B70) was trading at EUR 4.42 at Lang & Schwarz on October 15, 2026 at 1:11 p.m. CEST. Futu News reported on October 12, 2026 that UBS had cut its 2026 organic sales growth forecast for Haleon from 3.4 percent to 3.1 percent. The forecast puts seasonal execution ahead of the October reporting date.

UBS trims the growth view

UBS expects Haleon's third-quarter organic sales to rise 3.1 percent to GBP 2.92 billion, below the 3.4 percent Visible Alpha consensus cited by Futu News. The research house expects Haleon to move from its existing 3.00 percent to 5.00 percent full-year range toward a target of around 3.00 percent, reflecting weaker visibility for cough and cold demand.

The operating backdrop is mixed. Openbook reported that first-half 2026 revenue was GBP 5.602 billion, up 2.2 percent on a reported basis and 2.6 percent organically. Price contributed 2.1 percentage points of the organic increase, while volume and mix contributed 0.5 points.

What does margin growth mean?

Haleon's first-half adjusted operating margin reached 24.3 percent, up 120 basis points, while adjusted operating profit increased 8.2 percent at constant currency, according to Openbook. That comparison shows earnings growth running ahead of organic revenue growth, making productivity and mix important counterweights to softer volumes.

Three dated developments

On July 30, 2026, Haleon reported first-half revenue of GBP 5.602 billion and organic growth of 2.6 percent. On September 25, 2026, Yahoo Finance reported that UBS expected 3.1 percent third-quarter organic growth and retained a GBp 478.00 price target. On October 12, 2026, UBS cut its full-year growth forecast from 3.4 percent to 3.1 percent.

Next reporting date

Haleon lists October 29, 2026 as the date for its third-quarter trading statement. The release will test whether volume recovery can offset the weaker seasonal outlook.

Stock valuation and timing

The euro quote places Haleon in the after-Xetra-close perspective for German readers, while the LSE listing remains the primary market reference. The central question for the next update is whether the 2.6 percent first-half organic growth rate can accelerate enough to support the prior full-year range.

Haleon was trading at EUR 4.42 at Lang & Schwarz on October 15, 2026 at 1:11 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Haleon stock.